These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8889470)

  • 1. Promoter region polymorphism in the human TNF-alpha gene is not associated with lichen sclerosus.
    Clay FE; Cork MJ; Wilson AG; Crane AM; Lewis F; Harrington CI; Duff GW
    Exp Dermatol; 1996 Aug; 5(4):227-9. PubMed ID: 8889470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
    Wilson AG; de Vries N; Pociot F; di Giovine FS; van der Putte LB; Duff GW
    J Exp Med; 1993 Feb; 177(2):557-60. PubMed ID: 8426126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease.
    Azurdia RM; Luzzi GA; Byren I; Welsh K; Wojnarowska F; Marren P; Edwards A
    Br J Dermatol; 1999 Jan; 140(1):79-83. PubMed ID: 10215772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.
    Kroeger KM; Carville KS; Abraham LJ
    Mol Immunol; 1997 Apr; 34(5):391-9. PubMed ID: 9293772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
    Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW;
    Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.
    Clay FE; Cork MJ; Tarlow JK; Blakemore AI; Harrington CI; Lewis F; Duff GW
    Hum Genet; 1994 Oct; 94(4):407-10. PubMed ID: 7927338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -308 promoter polymorphism in the tumour necrosis factor gene in patients with lichen planus.
    Krasowska D; Chodorowska G; Koziol-Montewka M; Ksiazek A; Buraczynska M
    Acta Derm Venereol; 2005; 85(5):400-3. PubMed ID: 16159730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.
    Jones DE; Watt FE; Grove J; Newton JL; Daly AK; Gregory WL; Day CP; James OF; Bassendine MF
    J Hepatol; 1999 Feb; 30(2):232-6. PubMed ID: 10068101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
    Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lichen sclerosus premenarche: autoimmunity and immunogenetics.
    Powell J; Wojnarowska F; Winsey S; Marren P; Welsh K
    Br J Dermatol; 2000 Mar; 142(3):481-4. PubMed ID: 10735954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy.
    Hohjoh H; Nakayama T; Ohashi J; Miyagawa T; Tanaka H; Akaza T; Honda Y; Juji T; Tokunaga K
    Tissue Antigens; 1999 Aug; 54(2):138-45. PubMed ID: 10488740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
    McManus R; Wilson AG; Mansfield J; Weir DG; Duff GW; Kelleher D
    Eur J Immunol; 1996 Sep; 26(9):2113-8. PubMed ID: 8814255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.
    Wilson AG; Symons JA; McDowell TL; McDevitt HO; Duff GW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3195-9. PubMed ID: 9096369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.
    Cookson S; Constantini PK; Clare M; Underhill JA; Bernal W; Czaja AJ; Donaldson PT
    Hepatology; 1999 Oct; 30(4):851-6. PubMed ID: 10498633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts.
    Evans PC; Smith S; Hirschfield G; Rigopoulou E; Wreghitt TG; Wight DG; Taylor CJ; Alexander GJ
    J Hepatol; 2001 May; 34(5):711-5. PubMed ID: 11434617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of HLA-B*08 and HLA-B*18 in four siblings with Lichen sclerosus.
    Sentürk N; Aydin F; Birinci A; Yildiz L; Cantürk T; Durupinar B; Turanli AY
    Dermatology; 2004; 208(1):64-6. PubMed ID: 14730240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation.
    Brinkman BM; Zuijdeest D; Kaijzel EL; Breedveld FC; Verweij CL
    J Inflamm; 1995-1996; 46(1):32-41. PubMed ID: 8832970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.
    Rezaieyazdi Z; Afshari JT; Sandooghi M; Mohajer F
    Rheumatol Int; 2007 Dec; 28(2):189-91. PubMed ID: 17763852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis.
    He B; Navikas V; Lundahl J; Söderström M; Hillert J
    J Neuroimmunol; 1995 Dec; 63(2):143-7. PubMed ID: 8550811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
    Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
    J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.